
Benjamin Shneider MD
Pediatric Hepatology and Liver Transplantation
Professor, Pediatrics, Baylor College of Medicine Chief of Section, Pediatric Gastroenterology, Hepatology and Nutrition
Join to View Full Profile
6701 Fannin St.Pediatric Gastroenterology, Hepatology and NutritionHouston, TX 77030
Phone+1 832-822-3608
Dr. Shneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1986 - 1989
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986
- Stanford UniversityB.S, Chemistry, 1982
Certifications & Licensure
- TX State Medical License 2014 - 2026
- PA State Medical License 2007 - 2014
- NY State Medical License 1997 - 2013
- CT State Medical License 1989 - 1997
- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Awards, Honors, & Recognition
- Best Doctors in America 2007
- Elected Member The American Society for Clinical Investigation, 2005
- America's Top Pediatricians: Pediatric Gastroenterology 2004, 2008
- Join now to see all
Clinical Trials
- A Prospective Database of Infants With Cholestasis Start of enrollment: 2004 Apr 21
- Biliary Atresia Study in Infants and Children Start of enrollment: 2006 May 16
- Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) Start of enrollment: 2007 Nov 30
- Join now to see all
Publications & Presentations
PubMed
- Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2-4 Weeks of Life: Clinical Report.Sanjiv Harpavat, Susan W Aucott, Saul J Karpen, Benjamin L Shneider, Kasper Wang
Pediatrics. 2025-02-18 - Bile acid and microbiome interactions in the developing child.Mary Elizabeth M Tessier, Benjamin L Shneider, Joseph F Petrosino, Geoffrey A Preidis
Journal of Pediatric Gastroenterology and Nutrition. 2025-02-17 - Prospective Analysis of Liver Stiffness Measurement by Vibration Controlled Transient Elastography as a Predictor of Outcomes in Biliary Atresia.Jean P Molleston, Nathan P Goodrich, Wen Ye, Daniel H Leung, Ronald J Sokol
Gastroenterology. 2025-02-01
Journal Articles
- Accuracy of the Pediatric End-Stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant CandidatesRobert H Squires, Benjamin L Shneider, JAMA
- Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external biliary diversionJ. Pediatr. Gastroenterol. Nutr, 1/1/2015
- Byler's Disease-Early natural history, A single center case seriesJ. Pediatr. Gastroenterol. Nutr, 1/1/2015
- Join now to see all
Books/Book Chapters
Lectures
- Translational Investigations of Byler's DiseaseHouston, TX - 1/16/2015
- Stratifying Risk and Individualizing Care for Portal Hypertenson- Controversies and Challenges in PediatricsBaveno, Italy - 1/11/2015
- Controversies in the Management of Varices in ChildrenBaveno, Italy - 1/11/2015
- Join now to see all
Other
- ATP8B1 Deficiency.GeneReviews
University of Washington, Seattle, WA - 1/1/2009 - Low-gGT Familial Interhepatic CholestasisGeneReviews at GeneTests: Medical Genetics Information Resource
http://www.genetests.org
University of Washington, Seattle, WA - 1/1/2006 - Developmental aspects of hepatic bile acid transport. Proceedings of the 2nd Ringberg conference on cell biology and molecular basis of liver transportProjekt
Verlag, Dortmund - 1/1/1995
Press Mentions
- Maraxilibat Reduces Debilitating Itching in Children with Alagille SyndromeNovember 19th, 2020
- Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with MaralixibatNovember 15th, 2020
- Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor DayNovember 12th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: